Auro Laboratories Ltd Financials
Company Logo

Auro Laboratories Ltd Financial Statement

Auro Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue7.53
Operating Expense6.59
Net Profit0.39
Net Profit Margin5.18
Earning Per Share0.63
EBIDTA1.00
Effective Tax Rate2.13

Auro Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual53.64
Operating Expenses Annual42.97
Operating Profit Annual12.17
Interest Annual0.74
Depreciation1.09
Net Profit Annual7.79
Tax Annual2.55

Auro Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning2.42
Cash Flow from Operations18.81
Cash Flow from Investing-38.67
Cash Flow from Financing19.09
Cash Flow at the End1.65

Auro Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)22.71
PBIT Margin (%)20.67
PBT Margin (%)-7.24
Net PROFIT Margin (%)14.52
Return On Networth / Equity (%)20.46
Return On Networth /Employed (%)20.37
Return On Assets (%)14.38
Total Debt / Equity (X)0.43
Asset Turnover Ratio (%)0.99

Auro Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual22.15
Total Current Assets Annual30.85
Non Current Assets Annual54.88
Total Shareholders Funds Annual41.96
Total Assets Annual85.73

Auro Laboratories Ltd Earning Calls

No Data Availabe

FAQS on Auro Laboratories Ltd Financials

As of Jun 9, 2025, Auro Laboratories Ltd has a market capitalization of 143.69 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Auro Laboratories Ltd is not with a debt-to-equity ratio of 1.05.

In FY 2024 , Auro Laboratories Ltd recorded a total revenue of approximately 19.40 Cr marking a significant milestone in the company's financial performance.

Auro Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.7% and -0.5% annually, respectively..

Auro Laboratories Ltd's current PE ratio is 78.09.

Auro Laboratories Ltd's ROCE averaged 10.0% from the FY ending March 2023 to 2025, with a median of 10.5%. It peaked at 16.2% in March 2024, reflecting strong capital efficiency over the period..

Auro Laboratories Ltd's latest EBIT is Rs. 2.96 Cr, surpassing the average EBIT of Rs. 6.10 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions